A Study to Analyze the Occurrence of Transformation From Myelodysplastic Syndrome to Acute Myeloid Leukemia in Patients With Myelodysplastic Syndrome Who Received Revlimid® 5 mg Capsules and Who Are Continuing or no Longer Continuing Revlimid Treatment

NCT02921815 · clinicaltrials.gov ↗
COMPLETED
Status
84
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Celgene